Get In Touch

Macula is the oval yellowish area surrounding the focal point of the retina in the eye. Macular edema is the state when liquid and protein begin collecting under the macula leading to swelling in the eye. Focal vision of the eye gets mutilated because of this swelling. The retina is the light-delicate tissue at the back of the eye and the macula is the piece of the retina in charge of sharp, straight-ahead vision. Diabetic retinopathy is the main reason for macular edema which happens because of diabetes. Macular edema can likewise be analyzed in quiet after eye surgery for waterfall, glaucoma, or retinal illness. Ailments which harm the vein in the retina can cause macular edema. Wavy or foggy vision to observable vision misfortune are essential side effects of macular edema. On the off chance that one eye influenced, there is half likelihood that other eye can likewise be influenced. Treatment for macular edema depends on why it is caused, and may take several months to resolve. During this time, it is important to follow the treatment regimen thoroughly.

On the basis of type, the macular edema market is divided into two types: cystoids macular edema (CME) and diabetic macular edema (DME). On the basis of treatment, the market is divided into drug therapy and laser treatment. The drug therapy segment is growing at a faster rate than the laser treatment segment as many ophthalmologists prefer drug therapy as the first line therapy to cure the disease. Moreover, laser treatment is costly as compared to drug therapy. On the basis of tests, the macular edema treatment market is segmented into visual acuity test; dilated exam test; and tonometry test. The adjustment in way of life have the expanded rate of diabetic patients is significant driving variables of macular therapeutics advertise comprehensively. Several eye disorders are caused due to changing climatic conditions. Growing aging population has led to increased occurrence of eye infections. Disappointment of eye surgery waterfall, glaucoma, or retinal ailment can likewise rise the market of macular edema therapeutics around the world. Limited number of approved drugs and high cost involved in laser treatment hinders the growth of the market.

Geographically, North America and Europe are mature markets for diabetic macular edema because a large proportion of the population suffers from diabetes. Lucentis and Ozurdex drugs have major market share in the therapeutics market. The market in Asia Pacific is also growing at a fast pace and India is set to play a major role as in 2015 (according to International Diabetes Federation) around 69.1 million cases of diabetes was reported in India and half of them affected with visual impairments. The Middle East & Africa market for macular edema is driven by the developing predominance of vision impedance. Advancement in the field of medicine is a key factor driving the development of the market. Expanding geriatric population around the district along with an expansion in the discretionary cash flow of the general population are the other driving components.

Some of the major companies operating in the macular edema market are Novartis, Roche, Allergan, Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer Inc. Bayer AG, and Bausch & Lomb Incorporated.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Macular Edema Market

Pre Book